Drug profile · INN
tabelecleucel
EBVALLO
- Patents linked
- 0
- News articles
- 2
Quick answer
tabelecleucel (EBVALLO) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN tabelecleucel
Brand EBVALLO
Related news
Atara Biotherapeutics Receives FDA Complete Response Letter for EBVALLO Cancer Treatment, Faces Securities Class Action
Atara Biotherapeutics' EBVALLO cancer therapy receives FDA Complete Response Letter, delaying approval as company faces securities class action lawsuit deadline May 22, 2026.
FDA Issues Complete Response Letter for Atara Biotherapeutics' EBVALLO Cancer Treatment, Triggering Securities Lawsuit
Atara Biotherapeutics receives FDA Complete Response Letter for EBVALLO (tabelecleucel) cancer treatment, leading to securities class action lawsuit deadline.
Frequently asked questions
What is tabelecleucel?
tabelecleucel (EBVALLO) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for tabelecleucel?
EBVALLO is a marketed brand name for tabelecleucel. Check FDA Drugs@FDA for the current US label holder and prescribing information.